Home

MYLLE H MANGUM

CIK 1175893 · last filed 2024-03-12

MYLLE H MANGUM is a corporate insider who has filed 170 SEC Form 4 insider transactions across 8 companies since 2007. The most recent filing shows the insider was granted $1.9K of B on Mar 12, 2024. Across all open-market trades the lifetime net is −$3.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.3M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.35M

Companies

8

Total Filings

170

Lifetime Open-Market Net

-$3.21M

Filer Profile

Reported Address
3231 S E SIXTH AVENUE
TOPEKA, KS 66607
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
B Director 27,826 $44.87 $1.25M -$1.99M 107 2024-03-12
HVT.A Director 3,519 $28.36 $99.8K -$1.06M 25 2023-05-19
EXPRESS, INC. (EXPR) Delisted Director 14,184 $0.83 $11.8K -$159.6K 14 2022-06-09
PRGX GLOBAL, INC. (PRGX) Delisted Director 0 — — $0 9 2021-03-04
COLLECTIVE BRANDS, INC. (PSS) Delisted Director 0 — — $0 7 2012-10-10
EMAGEON INC (EMAG) Delisted Director — $20.38 — $0 1 2008-12-15
RESPIRONICS INC (RESP) Delisted Director 0 $50.79 $0 $0 3 2008-03-10
EMAGEON INC (WEBM) Delisted Director — — — $0 1 2007-05-29

Recent Filings

170 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-03-12 B Grant (A) +49 $1.9K EDGAR
2024-02-13 B Grant (A) +1,033 $0 EDGAR
2023-12-12 B Buy (P) +66 $1.9K EDGAR
2023-09-25 B Grant (A) +52 $1.9K EDGAR
2023-06-13 B Buy (P) +45 $1.9K EDGAR
2023-05-23 B Grant (A) +973 $0 EDGAR
2023-05-19 HVT Notice (144) −5,158 -$135.6K EDGAR
2023-05-19 HVT.A Sell (S) −5,158 -$135.6K EDGAR
2023-05-10 HVT.A Grant (A) +3,519 $90.0K EDGAR
2023-03-14 B Buy (P) +48 $1.9K EDGAR
Showing 1–10 of 170
Page 1 of 17
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.